Hinge Health (HNGE) Cash & Equivalents (2023 - 2026)

Hinge Health's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $186.7 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 35.29% year-over-year to $186.7 million; the TTM figure through Mar 2026 stood at $186.7 million (down 35.29% YoY), while the FY2025 annual figure was $208.0 million, down 30.85% from the prior year.
• Cash & Equivalents came in at $186.7 million for Q1 2026 at Hinge Health, down from $208.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $300.8 million in Q4 2024 to a low of $186.7 million in Q1 2026.
• A 4-year average of $237.2 million and a median of $235.0 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents gained 28.02% in 2024 and tumbled 35.29% in 2026, its largest moves.
• Hinge Health's Cash & Equivalents stood at $235.0 million in 2023, then rose by 28.02% to $300.8 million in 2024, then tumbled by 30.85% to $208.0 million in 2025, then declined by 10.25% to $186.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $186.7 million, $208.0 million, and $214.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison